<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are common causes of ineffective hematopoiesis and cytopenias in the elderly </plain></SENT>
<SENT sid="1" pm="."><plain>Various myelosuppressive and proinflammatory cytokines have been implicated in the high rates of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and hematopoietic suppression seen in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We have previously shown that p38 MAPK is overactivated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> hematopoietic progenitors, which led to current clinical studies of the selective p38alpha inhibitor, SCIO-469, in this disease </plain></SENT>
<SENT sid="3" pm="."><plain>We now demonstrate that the myelosuppressive cytokines TNFalpha and IL-1beta are secreted by bone marrow (BM) cells in a p38 MAPK-dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain>Their secretion is stimulated by paracrine interactions between BM stromal and mononuclear cells and cytokine induction correlates with CD34+ stem cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in an <z:mp ids='MP_0001845'>inflammation</z:mp>-simulated in vitro bone marrow microenvironment </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment with SCIO-469 inhibits TNF secretion in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> bone marrow cells and protects cytogenetically <z:mpath ids='MPATH_458'>normal</z:mpath> progenitors from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> ex vivo </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, p38 inhibition diminishes the expression of TNFalpha or IL-1beta-induced proinflammatory chemokines in BM stromal cells </plain></SENT>
<SENT sid="7" pm="."><plain>These data indicate that p38 inhibition has anti-inflammatory effects on the bone marrow microenvironment that complements its cytoprotective effect on progenitor survival </plain></SENT>
<SENT sid="8" pm="."><plain>These findings support clinical investigation of p38alpha as a potential therapeutic target in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and other related diseases characterised by inflammatory <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> </plain></SENT>
</text></document>